K2M's ALEUTIAN Spacer Systems Receive FDA Clearance To Be Marketed As Intervertebral Body Fusion Devices

Main Category: Neurology / Neuroscience
Also Included In: Regulatory Affairs / Drug Approvals;  Medical Devices / Diagnostics
Article Date: 16 Jul 2009 - 0:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:not yet rated


K2M, Inc., a spinal device company developing innovative solutions for the treatment of complex spinal pathologies, announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its ALEUTIAN® Spacer Systems as intervertebral body fusion devices. The ALEUTIAN family of five different systems offers a full array of anatomically designed PEEK-OPTIMA® interbody options, including the Anterior-Lumbar Interbody Fusion (ALIF), Small-Anterior (Cervical), Posterior-Lumbar Interbody Fusion (PLIF), Anatomically Narrow (AN), and Transforaminal-Lumbar Interbody Fusion (TLIF).

ALEUTIAN features radiolucent properties which have the potential to increase visualization of bone graft, while allowing for more accurate fusion assessment. In addition, the elastic modulus, a physical property of the material, more closely matches that of cortical bone for load sharing with the potential to minimize stress shielding and enhance fusion results. The bulleted nose allows for easier insertion and distraction, and the self-retaining teeth can potentially provide post-operative stabilization of the implant.

According to Dr. Raphael Roybal, Orthopedic Spine Surgeon at the Savannah Spine Institute, "The ALEUTIAN family of interbody PEEK cages provides a reproducible bridge where successful arthrodesis crosses over to superior anatomical reconstruction."

"FDA clearance for the ALEUTIAN Spacer Systems to be marketed as intervertebral body fusion devices provides surgeons with multiple surgical applications in the cervical and lumbar spine for the treatment of Degenerative Disc Disease (DDD) and Spondylolisthesis, as well as more complex applications," stated Eric Major, K2M's President and CEO. "The anatomically designed implants and differentiated surgical instruments facilitate and streamline surgical applications. The ALEUTIAN family of products complements our comprehensive product portfolio of best-in-class systems for treating all types of complex spinal pathologies."

Source
K2M, Inc.

Article adapted by Medical News Today from original press release.
Visit our neurology / neuroscience section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
K2M, Inc.. "K2M's ALEUTIAN Spacer Systems Receive FDA Clearance To Be Marketed As Intervertebral Body Fusion Devices." Medical News Today. MediLexicon, Intl., 16 Jul. 2009. Web.
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/157652.php>

APA
K2M, Inc.. (2009, July 16). "K2M's ALEUTIAN Spacer Systems Receive FDA Clearance To Be Marketed As Intervertebral Body Fusion Devices." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/157652.php.

Please note: If no author information is provided, the source is cited instead.


Neurology / Neuroscience

Most Popular Articles



Follow Our Neurology News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Neurology / Neuroscience Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »